arrow
T

Thozhukat Sathyapalan

hull university teaching hospitals nhs trust
H指数:59
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Recurrent Diabetes-Related Hospital Admissions and Diabetes Distress: Real-World Evidence From the Association of British Clinical Diabetologists (ABCD) National Freestyle Libre Audit

糖尿病相关住院再入院与糖尿病困扰:英国临床糖尿病协会(ABCD)全国自由风格利布里审计的真实世界证据

2026-09-300
PRE
Dose-Normalised Time in Range (dn-TIR) Improves Following Hybrid Closed-Loop (HCL) Therapy in Type 1 Diabetes: A Real-World Cohort Study From Australia and the United Kingdom

剂量标准化时间在范围内(dn-TIR)在1型糖尿病中随混合闭环(HCL)治疗后改善:一项来自澳大利亚和英国的真实世界队列研究

2026-09-100
OAAI
Update of the EuroGuiDerm evidence-based guideline for the treatment of acne—Short version

《EuroGuiDerm基于证据的痤疮治疗指南更新——简版》

2026-03-180
OAAI
Differential Expression of Complement Pathway Components in Unexplained Infertility Versus Male Factor Infertility: Insights from an Exploratory Pilot Study

不明原因不孕与男性因素不孕中补体通路成分的差异表达:一项探索性试点研究的见解

2025-10-190
OAAI
Adding empagliflozin to ongoing metformin improves metabolic profile, tg-g and fib-4 indexes and liver function tests in type 2 diabetic patients with NAFLDS, a clinical trial

将恩格列净添加到正在进行的二甲双胍治疗中,可改善2型糖尿病合并NAFLDS患者的代谢状况、TG-G和Fib-4指数以及肝功能检查结果,一项临床试验。

2025-08-250
PRE
Addition of sitagliptin to ongoing metformin improved metabolic profile and pancreatic function via normalizing inflammatory cytokines’ levels in patients with type 2 diabetes, a randomized double-blinded clinical trial

将西格列汀添加到持续使用的二甲双胍中,可通过正常化炎症细胞因子水平来改善2型糖尿病患者的代谢状况和胰腺功能,一项随机双盲临床试验。

2025-07-260
PRE